Antineoplastic evaluation of Pacific basin marine algae

Area of Science:

• Marine Biology
• Pharmacology
• Natural Products Chemistry

Background:

• Marine organisms, particularly algae, are a rich source of bioactive compounds.
• Natural products are crucial in the development of novel anticancer therapeutics.
• Pacific island marine flora represents an underexplored resource for drug discovery.

Purpose of the Study:

• To screen marine alga extracts from Pacific islands for cytotoxic activity.
• To evaluate the antitumor potential of these extracts against specific cancer models.
• To identify marine algae with significant anticancer properties and low toxicity.

Main Methods:

• Collection and extraction of 107 marine alga specimens from Pacific islands.
• In vivo testing of algal extracts using P-388 lymphocytic leukemia model in mice.
• In vivo testing of algal extracts using Ehrlich ascites tumor model in mice.
• Assessment of antitumor activity and toxicity profiles of the tested extracts.

Main Results:

• Several marine alga extracts exhibited significant antitumor activity in both P-388 lymphocytic leukemia and Ehrlich ascites tumor models.
• A subset of these active extracts demonstrated a notable lack of toxicity in the tested animal models.
• The findings indicate a promising therapeutic index for certain marine algae-derived compounds.

Conclusions:

• Marine algae from Pacific islands are a valuable source of novel anticancer drug leads.
• Specific algal extracts show potential for development into chemotherapeutic agents with favorable safety profiles.
• Further investigation into the active compounds and mechanisms of action is warranted.